Collaboration, License, and Other Agreements - Teva Narrative (Details) - USD ($) $ in Millions	12 Months Ended				72 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2016	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Revenues	$ 12,172.9	$ 16,071.7	$ 8,497.1
Teva
Disaggregation of Revenue [Line Items]
Up-front payment received				$ 250.0
Revenues					$ 120.0
Teva | Other operating income
Disaggregation of Revenue [Line Items]
Cumulative catch-up adjustment to revenue, modification of contract	$ 31.9